Covered recipient · General Payments record
SALMAN S ALY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$9,636.17
- Reported across 316 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,043.83 | 28 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $332.04 | 4 |
| ABBVIE INC. | $272.27 | 14 |
| REVANCE THERAPEUTICS, INC. | $240.70 | 5 |
| Smith+Nephew, Inc. | $104.16 | 1 |
| PFIZER INC. | $54.09 | 2 |
| Galderma Laboratories, L.P. | $23.82 | 1 |
| SHIELD THERAPEUTICS INC | $16.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.95 | 01/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407909 | CMS |
| ABBVIE INC. | $6.66 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407911 | CMS |
| ABBVIE INC. | $10.54 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407913 | CMS |
| ABBVIE INC. | $8.11 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407915 | CMS |
| ABBVIE INC. | $19.47 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407917 | CMS |
| ABBVIE INC. | $10.10 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407919 | CMS |
| ABBVIE INC. | $16.57 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407921 | CMS |
| ABBVIE INC. | $18.27 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407923 | CMS |
| ABBVIE INC. | $6.39 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407925 | CMS |
| ABBVIE INC. | $5.47 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407927 | CMS |
| ABBVIE INC. | $136.66 | 07/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407929 | CMS |
| ABBVIE INC. | $1.01 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407931 | CMS |
| ABBVIE INC. | $7.66 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407933 | CMS |
| ABBVIE INC. | $12.41 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201407935 | CMS |
| Galderma Laboratories, L.P. | $23.82 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234614001 | CMS |
| MIMEDX Group, Inc. | $35.71 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235836716 | CMS |
| MIMEDX Group, Inc. | $42.86 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235836718 | CMS |
| MIMEDX Group, Inc. | $138.51 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235836720 | CMS |
| MIMEDX Group, Inc. | $114.96 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235836722 | CMS |
| PFIZER INC. | $28.99 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231682019 | CMS |
| PFIZER INC. | $25.10 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231286888 | CMS |
| REVANCE THERAPEUTICS, INC. | $60.48 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251157834 | CMS |
| REVANCE THERAPEUTICS, INC. | $60.48 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251157836 | CMS |
| REVANCE THERAPEUTICS, INC. | $12.49 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251157838 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.32 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251157840 | CMS |
| REVANCE THERAPEUTICS, INC. | $76.93 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251157842 | CMS |
| SHIELD THERAPEUTICS INC | $16.75 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249629385 | CMS |
| Smith+Nephew, Inc. | $104.16 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242219561 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.